Concepedia

Publication | Open Access

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

100

Citations

27

References

2005

Year

References

YearCitations

Page 1